Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Share-based Compensation: 2014-2025

Historic Share-based Compensation for Ocugen (OCGN) over the last 12 years, with Sep 2025 value amounting to $2.0 million.

  • Ocugen's Share-based Compensation rose 4.44% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year increase of 4.25%. This contributed to the annual value of $7.4 million for FY2024, which is 19.42% down from last year.
  • According to the latest figures from Q3 2025, Ocugen's Share-based Compensation is $2.0 million, which was up 7.10% from $1.8 million recorded in Q2 2025.
  • Ocugen's 5-year Share-based Compensation high stood at $3.3 million for Q1 2022, and its period low was $833,000 during Q1 2021.
  • Its 3-year average for Share-based Compensation is $2.0 million, with a median of $1.9 million in 2024.
  • As far as peak fluctuations go, Ocugen's Share-based Compensation surged by 1,546.01% in 2021, and later plummeted by 35.46% in 2023.
  • Over the past 5 years, Ocugen's Share-based Compensation (Quarterly) stood at $2.7 million in 2021, then fell by 0.56% to $2.7 million in 2022, then crashed by 35.46% to $1.7 million in 2023, then grew by 8.94% to $1.9 million in 2024, then rose by 4.44% to $2.0 million in 2025.
  • Its Share-based Compensation stands at $2.0 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.9 million for Q1 2025.